Ligand profile
K0V
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_00203 — putative 8-amino-7-oxononanoate synthase/2-amino-3-ketobutyrate coenzyme A ligase
Identifiers
Database identifiers and provenance.
- Ligand ID
K0V- PDB
5qr6- UniProt (similar protein)
P22557- Target protein
- KP13_00203
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 58.6
- −1 ≤ LogP ≤ 5 1.38
- MW ≤ 500 Da 242.3
- LogP ≤ 5 1.38
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 1
- TPSA ≤ 140 Ų 58.6
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CC(C)(C)NC(=O)N1CCC(CC1)C(=O)OCCC(C)(C)NC(=O)N1CCC(CC1)C(=O)OC
InChI=1S/C12H22N2O3/c1-12(2,3)13-11(16)14-7-5-9(6-8-14)10(15)17-4/h9H,5-8H2,1-4H3,(H,13,16)InChI=1S/C12H22N2O3/c1-12(2,3)13-11(16)14-7-5-9(6-8-14)10(15)17-4/h9H,5-8H2,1-4H3,(H,13,16)
YNDIZCMKDPECRX-UHFFFAOYSA-NYNDIZCMKDPECRX-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00155
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand K0V →
- PDB RCSB structure 5qr6 →
- UniProt UniProt P22557 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “K0V”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00203.
PDB 32
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 1
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).